Related Experiment Video
Updated: Jun 3, 2025
12:19
Monitoring the Cancer-Immunity Cycle and Exploring Tumor Microenvironment Dynamics
Published on: June 7, 2024
836
Cervical Cancer Cells Use the CD95 and IL-2 Pathways to Promote Their Proliferation and Survival
Adriana Gutiérrez-Hoya1,2, Ivan Ortiz-Garrido1, Itzel Salazar-Valencia1,3
1Molecular Oncology Laboratory, Cell Differentiation and Cancer Research Unit, UMIEZ Campus II FES Zaragoza, National Autonomous University of Mexico, Mexico City 09230, Mexico.
Biomolecules
|January 8, 2025
Summary
Cervical cancer cells can exploit the IL-2 and CD95 pathways for growth. These pathways, normally for immune activation, may promote tumor proliferation and survival, not cell death.
Area of Science:
- Immunology
- Oncology
- Cell Biology
Background:
- Cervical cancer cells evade immune surveillance and cell death mechanisms.
- Interleukin-2 (IL-2) and CD95 pathways are crucial for immune response but can be co-opted by tumors.
- Understanding these pathways' roles in cervical cancer is vital for developing effective therapies.
Purpose of the Study:
- To investigate the role of IL-2 and CD95 signaling in cervical tumor cell proliferation and survival.
- To determine how cervical cancer cells (SiHa and HeLa) respond to IL-2 and CD95 pathway modulation.
Main Methods:
- Treatment of SiHa and HeLa cells with varying doses of IL-2.
- Treatment with CD95 agonist antibodies.
- Simultaneous treatment with IL-2 and CD95 agonist antibodies.
- Analysis of cell proliferation, CD95 receptor/ligand expression, and LC3B accumulation.
Main Results:
- Low-dose IL-2 (10 IU/mL) stimulated cervical cancer cell proliferation; high-dose IL-2 (100 IU/mL) decreased it.
- SiHa and HeLa cells express high levels of CD95 receptor and CD95 ligand (CD95L).
- Low-dose CD95 agonist treatment increased cell proliferation; combined high-dose IL-2 and CD95 agonist upregulated LC3B, indicating potential cytoprotective mechanisms, not apoptosis.
Conclusions:
- Cervical tumor cells can utilize IL-2 and CD95 pathways to promote their own proliferation.
- These pathways may activate cytoprotective mechanisms, contributing to cancer cell survival.
- Targeting these pathways requires careful consideration of dose-dependent effects and potential pro-survival roles in cervical cancer.
Related Concept Videos
01:22T Cell Activation and Clonal Selection
651
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
651
01:27Cytotoxic T Cells-mediated Immune Response
841
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
841
01:27Tumor Immunotherapy
472
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
472
02:40Cancer Stem Cells and Tumor Maintenance
4.7K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.7K
02:38Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
02:18Cancer
47.8K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
47.8K